RepliCel Life Sciences (TSE:RP) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
RepliCel Life Sciences has rescheduled its annual meeting to January 16, 2025, where shareholders will vote on the sale of assets and delisting from the TSX Venture Exchange. The company also announced the resignation of board member Jamie Mackay, who played a crucial role in maintaining company operations during challenging times.
For further insights into TSE:RP stock, check out TipRanks’ Stock Analysis page.